# Study of ISIS 681257 in Patients With Renal Impairment Compared to Healthy Patients

> **NCT03506854** · PHASE1 · COMPLETED · sponsor: **Akcea Therapeutics** · enrollment: 16 (actual)

## Conditions studied

- Renal Impairment

## Interventions

- **DRUG:** ISIS 681257

## Key facts

- **NCT ID:** NCT03506854
- **Lead sponsor:** Akcea Therapeutics
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-03-20
- **Primary completion:** 2018-10-11
- **Final completion:** 2018-10-11
- **Target enrollment:** 16 (ACTUAL)
- **Last updated:** 2019-05-22

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03506854

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03506854, "Study of ISIS 681257 in Patients With Renal Impairment Compared to Healthy Patients". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT03506854. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*